Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Medford AJ, Oshry L, Boyraz B, Kiedrowski L, Menshikova S, Butusova A, et al. TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis. Ther Adv Med Oncol. 2023;15:17588359231152844.

Hagemann IS, Bridge JA, Tafe LJ, Hameed MR, Moncur JT, Bellizzi AM, et al. Current Laboratory Testing Practices for Assessment of ERBB2/HER2 in Endometrial Serous Carcinoma and Colorectal Carcinoma. Arch Pathol Lab Med. 2023;147(10):1148-1157.

Sarwate M, Khaitan N, Alpert L, Tavberidze N, Zhang W, Panarelli N, et al. Gastric Glandular Siderosis but not Lamina Propria Siderosis is Associated With High Serum Ferritin Levels. Am J Surg Pathol. 2023;47(9):1052-1058.

Andriano TM, Tannenbaum R, Xu H, Magro CM. Linear IgA bullous dermatosis in the setting of angioimmunoblastic T-cell lymphoma. J Cutan Pathol. 2023;50(1):43-46.

Xie Q, Schenck EJ, Yang HS, Chen Y, Peng Y, Wang F. Faithful AI in Medicine: A Systematic Review with Large Language Models and Beyond. medRxiv. 2023.

Saoud C, Wakely PE, Pantanowitz L, Siddiqui MT, Ali SZ. Chondroblastoma: Cytomorphologic Analysis of 10 Cases with Review of the Literature. Acta Cytol. 2023;67(4):413-424.

Usui J, Salvatore SP, Yamagata K, Seshan SV. Clinicopathologic Spectrum of Renal Lesions Following Anti-TNF- α Inhibitor Therapy: A Single Center Experience. Kidney360. 2023;4(3):363-373.

Noch EK, Palma LN, Yim I, Bullen N, Qiu Y, Ravichandran H, et al. Insulin feedback is a targetable resistance mechanism of PI3K inhibition in glioblastoma. Neuro Oncol. 2023;25(12):2165-2176.

Bhinder B, Ferguson A, Sigouros M, Uppal M, Elsaeed AG, Bareja R, et al. Immunogenomic Landscape of Neuroendocrine Prostate Cancer. Clin Cancer Res. 2023;29(15):2933-2943.

Hwang JK, Magro CM, Lipner SR. Nail Unit Arteriovenous Hemangioma Presenting as Longitudinal Erythronychia. Skin Appendage Disord. 2023;9(4):300-305.